Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Age-Related Neovascular Macular Degeneration”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT05456828
What this trial is testing

ASKG712 in Patients With Neovascular Age-Related Macular Degeneration

Who this might be right for
Neovascular Age-related Macular Degeneration
Visara, Inc. 56
Testing effectiveness (Phase 2)Study completedNCT02713204
What this trial is testing

Anti-angiOpoeitin 2 Plus Anti-vascular eNdothelial Growth Factor as a therapY for Neovascular Age Related Macular Degeneration: Evaluation of a fiXed Combination Intravitreal Injection

Who this might be right for
Neovascular Age-Related Macular Degeneration
Regeneron Pharmaceuticals 365
Post-approval studies (Phase 4)Study completedNCT03022292
What this trial is testing

The IAI-OCTA Study; a Study of OCT-Angiography Analysis Efficacy

Who this might be right for
Wet Macular Degeneration
University of California, Los Angeles 26
Early research (Phase 1)Active Not RecruitingNCT06198413
What this trial is testing

LX102 in Patients With Neovascular Age-Related Macular Degeneration (nAMD)

Who this might be right for
Neovascular Age-Related Macular Degeneration
Innostellar Biotherapeutics Co.,Ltd 12
Post-approval studies (Phase 4)Study completedNCT02130024
What this trial is testing

A Comparison of Ranibizumab and Aflibercept for the Development of Geographic Atrophy in (Wet) AMD Patients

Who this might be right for
Age-Related Macular Degeneration
Novartis Pharmaceuticals 281
Not applicableActive Not RecruitingNCT06075147
What this trial is testing

The SPECTRUM Study: An Observational Study to Learn More About How Well Aflibercept 8 mg Works in Treating Visual Impairment Due to Neovascular Age-related Macular Degeneration or Diabetic Macula Edema

Who this might be right for
Visual ImpairmentNeovascular Age-related Macular Degeneration (nAMD)Diabetic Macula Edema (DME)
Bayer 2,500
Not applicableStudy completedNCT01682382
What this trial is testing

Association of Macular Pigment Optical Density (MPOD) and Genetic Variants in Complement Factor H in Subjects With Choroidal Neovascular (CNV)

Who this might be right for
Age-related Macular DegenerationChoroidal Neovascular Age-related Macular Degeneration
Sequenom, Inc. 45
Early research (Phase 1)Study completedNCT03814291
What this trial is testing

A Dose Escalation Study of IBI302 in Patients With Wet Age-related Macular Degeneration

Who this might be right for
Neovascular Age-related Macular Degeneration
Innovent Biologics (Suzhou) Co. Ltd. 31
Large-scale testing (Phase 3)Study completedNCT07389577
What this trial is testing

Compare JL14002 to Lucentis® in Subjects With Wet Age-related Macular Degeneration (wAMD)

Who this might be right for
Wet Age-related Macular Degeneration
Jecho Biopharmaceuticals Co., Ltd. 443
Testing effectiveness (Phase 2)Study completedNCT00056823
What this trial is testing

Intravitreal Injections of rhuFab V2 in Combination With Visudyne in Subjects With Age Related Macular Degeneration (AMD)

Who this might be right for
Age-Related Maculopathy
Genentech, Inc. 168
Large-scale testing (Phase 3)Study completedNCT03930641
What this trial is testing

Study of the Safety of Brolucizumab 6 mg in Prefilled Syringe in Patients With Neovascular Age Related Macular Degeneration

Who this might be right for
Neovascular Age Related Macular Degeneration
Novartis Pharmaceuticals 34
Not applicableUnknownNCT00893724
What this trial is testing

Supplemental Adjuvants for Intracellular Nutrition and Treatment

Who this might be right for
Neovascular Age-related Macular DegenerationDiabetic Macular Edema
Mid-Atlantic Retina Consultations, Inc. 60
Post-approval studies (Phase 4)Study completedNCT02142296
What this trial is testing

Eylea to Treat Retinal Pigment Epithelial Detachment (RPED) Secondary to Wet Age-Related Macular Degeneration (wAMD)

Who this might be right for
Retinal Pigment Epithelial Detachment Secondary to Age-related Macular Degeneration
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 37
Not applicableStudy completedNCT07074054
What this trial is testing

Aflibercept 8 mg for nAMD: Early Anatomical and Functional Changes

Who this might be right for
Presence of Retinal FluidChanges in Macular Pigment Optical Density
Federico II University 40
Not applicableStudy completedNCT02367365
What this trial is testing

Neovascular Morphology and Persistent Disease Activity Among Patients With NV AMD

Who this might be right for
Neovascular Age-Related Macular Degeneration
Duke University 75
Post-approval studies (Phase 4)Ended earlyNCT00327470
What this trial is testing

An Open Label Trial to Investigate Macugen for the Preservation of Visual Function in Subjects With Neovascular AMD

Who this might be right for
Age Related Macular Degeneration (AMD)Macular DegenerationChoroidal Neovascularization (CNV)
Pfizer 288
Large-scale testing (Phase 3)Study completedNCT05989126
What this trial is testing

Study to Evaluate an 8 mg Aflibercept (EYLEA®) Prefilled Syringe (PFS)

Who this might be right for
Diabetic Macular Edema (DME)Neovascular Age-Related Macular Degeneration (nAMD)
Regeneron Pharmaceuticals 35
Large-scale testing (Phase 3)Study completedNCT01780935
What this trial is testing

Efficacy and Safety of Two Treatment Regimens of 0.5 mg Ranibizumab Intravitreal Injections Guided by Functional and/or Anatomical Criteria, in Patients With Neovascular Age-related Macular Degeneration

Who this might be right for
Neovascular Age-related Macular Degeneration
Novartis Pharmaceuticals 671
Testing effectiveness (Phase 2)Active Not RecruitingNCT06087458
What this trial is testing

Study of VOY-101 in Patients With Advanced Non-Neovascular Age-Related Macular Degeneration

Who this might be right for
Age-Related Macular DegenerationGeographic AtrophyNon-neovascular AMD+1 more
Perceive Biotherapeutics, Inc. 60
Post-approval studies (Phase 4)Study completedNCT01958918
What this trial is testing

Efficacy of Ranibizumab Prn Treatment Compared to Aflibercept Bimonthly Intravitreal Injections on Retinal Thickness Stability in Patients With Wet AMD

Who this might be right for
Neovascular Age-related Macular Degeneration
Novartis Pharmaceuticals 712
Next Page